Exhibitors at UBIFRANCE French Pavilion
Exhibitors at UBIFRANCE French Pavilion
Exhibitors at UBIFRANCE French Pavilion
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
METABRAIN RESEARCH<br />
4 avenue François Mitterrand<br />
91380 CHILLY-MAzARIN - FRANCE<br />
Phone: +33 1 69 19 41 50<br />
Fax: +33 1 69 19 41 51<br />
Email: contact@metabrainresearch.com<br />
Web site: www.metabrainresearch.com<br />
Contact: Valérie AUTIER<br />
Metabrain Research is a drug discovery Partnering Research Organis<strong>at</strong>ion (PRO)<br />
expert in metabolic disorders.<br />
Metabrain Research has a sustainable business model of early stage drug discovery<br />
research, based on a mix of research alliances, early stage collabor<strong>at</strong>ions and contract<br />
research. Our objectives <strong>at</strong> BIO :<br />
1) propose research alliances on first-in-class programs<br />
2) contribute to drug discovery programs through contract research<br />
3) initi<strong>at</strong>e collabor<strong>at</strong>ions building on the connections between metabolic and CNS<br />
disorders to valid<strong>at</strong>e novel targets and discover new drugs.<br />
MILLEGEN<br />
Immeuble Biostep - B<strong>at</strong>. A<br />
Rue Pierre et Marie Curie<br />
31681 LABEGE - FRANCE<br />
Phone: +33 5 61 28 70 10<br />
Fax: +33 5 61 28 70 11<br />
Email: contact@millegen.com<br />
Web site: www.millegen.com<br />
Contacts: Anne DEFLISQUE<br />
Philippe MONDON<br />
Millegen is expert in discovery and genetic engineering of therapeutic antibodies.<br />
MilleGen’s antibody pl<strong>at</strong>form allows the gener<strong>at</strong>ion of fully human monoclonal<br />
antibodies and lead optimiz<strong>at</strong>ion using a powerful Directed Molecular Evolution<br />
technology. Our specificity is to have a proprietary library comprising several billion<br />
different fully human antibodies with an original diversity. Our efficiency was proven<br />
through several successful projects with industrial partners. MilleGen has built<br />
a pipeline of therapeutic antibodies. We are looking to associ<strong>at</strong>e human antibody<br />
candid<strong>at</strong>es to original targets to develop with you a targeted therapy.<br />
50
Change language